Loading...
Loading...
ZYXI| Name | Value |
|---|---|
| Revenues | 42.2M |
| Cost of Revenue | 9.3M |
| Gross Profit | 32.9M |
| Operating Expense | 32.6M |
| Operating I/L | 1.7M |
| Other Income/Expense | 1.3M |
| Interest Income | 0.1M |
| Pretax | 1.6M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | 1.6M |
Zynex, Inc. designs, manufactures, and markets medical devices for pain management, muscle activation, and rehabilitation. Its products include electrical stimulation devices such as NexWave, NeuroMove, InWave, and E-Wave, as well as private labeled products like electrodes and batteries. The company also offers fluid monitoring systems and noninvasive medical devices for hemodynamic and pulse oximetry monitoring. Zynex sells its products primarily in the United States through a direct sales force. The company's revenue is generated from the sales of its medical devices and related products for use in various medical applications.
